Table 3 Post-hoc analysis comparing levels of Gal-4 in obese subjects with or without prevalent diabetes
Subjects without diabetes | Subjects with diabetes | |||
|---|---|---|---|---|
n = 255 | n = 262 | |||
HO n = 198; NHO n = 57 | HO n = 209; NHO n = 53 | |||
Model 1 | OR (CI95%) | p | OR (CI95%) | p |
Galectin-4 | 1.52 (0.99–2.53) | 0.111 | 2.45 (1.38–4.35) | 0.002 |
Age | 1.06 (1.01–1.12) | 0.024 | 1.07 (1.01–1.13) | 0.016 |
Sex | 1.08 (0.56–2.09) | 0.824 | 0.62 (0.29–1.35) | 0.228 |
Model 2 | OR (CI95%) | p | OR (CI95%) | p |
|---|---|---|---|---|
Galectin-4 | 1.45 (0.84–2.49) | 0.172 | 2.26 (1.25–4.07) | 0.007 |
Age | 1.06 (1.00-1.12) | 0.039 | 1.03 (0.97–1.10) | 0.279 |
Sex | 0.93 (0.44–1.96) | 0.843 | 0.41 (0.18–0.97) | 0.043 |
Total choles§terol | 0.92 (0.67–1.25) | 0.574 | 0.60 (0.44–0.81) | 0.001 |
Current smoker | 1.97 (0.74–5.29) | 0.177 | 1.01 (0.38–2.68) | 0.991 |
Hypertension | 1.09 (0.46–2.57) | 0.849 | 0.84 (0.23–3.03) | 0.784 |
BMI | 1.08 (0.95–1.23) | 0.250 | 0.94 (0.86–1.03) | 0.200 |
FPG | 1.89 (0.88–3.99) | 0.063 | 1.15 (0.80–1.63) | 0.454 |